Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,914 | 0 | 0 | N/A | 0 |
| Marketable Securities | 2,501 | 0 | 0 | N/A | 0 |
| TOTAL | $32,036 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 845 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 1,923 | 0 | 0 | 0 | 0 |
| TOTAL | $2,768 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $34,804 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,271 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 3,108 | 0 | 0 | N/A | 0 |
| TOTAL | $5,460 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 81 | N/A | N/A | N/A | N/A |
| TOTAL | $250 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,710 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,284 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | 0 | 0 | N/A | 0 |
| Retained earnings | -99,721 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | 81,029 | 0 | 0 | 0 | 0 |
| TOTAL | $29,094 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $34,804 | $0 | $0 | $0 | $0 |